ESAB (ESAB) Stock Faces Margin Squeeze After Sharp EPS Drop
ESAB Corporation ESAB | 0.00 |
ESAB stock slipped 2.8% to US$91.86 into the close, yet the real story sits in the income statement. The market latched onto a softer quarterly earnings per share print while looking past a heavier pressure point. Net profit over the last twelve months sits at US$196.3m on more than US$3.0b of revenue, which leaves a thinner cushion than many investors in industrial tools and welding equipment might prefer.
The sentiment reckoning today is about margins. Trailing net margin has compressed to 6.5%, and that squeeze, not the headline revenue line, is what is really steering emotion in ESAB stock.
Like ESAB's revenue scale but uneasy about that 6.5% net margin squeeze and thinner profit cushion? Benchmark it against 78 resilient stocks with low risk scores to see stocks where resilient balance sheets and profitability align more comfortably.
Q2 2026 Earnings Summary
- Revenue, Q2 2026 vs. Q2 2025: US$807.6m vs. US$715.6m (up 12.9%)
- Net Income from Continuing Operations, Q2 2026 vs. Q2 2025: US$33.4m vs. US$68.4m (down 51.2%)
- Basic EPS, Q2 2026 vs. Q2 2025: US$0.54 vs. US$1.13 (down 52.2%)
- Trailing Twelve Month Net Margin, Q2 2026 vs. Q2 2025: 6.5% vs. 10.2% (margin compression of 3.7 percentage points)
Prefer clear visuals instead of another wall of earnings tables and margin figures? See ESAB's full financial picture, including a focused look at its profitability trends and margins, in our latest company report for ESAB.
ESAB bull case meets mixed execution test
Optimists argue ESAB is becoming a higher margin, less cyclical workflow company, powered by equipment growth, automation and Eddyfi. Q2 gives some backing to that story. Total sales grew 13% with equipment and automation in double digits and both segments back to organic growth. The updated 2026 guide to US$3.0b to US$3.1b of core sales and US$615m to US$625m of adjusted EBITDA shows Eddyfi is already lifting the profit pool, with management pointing to roughly US$50m of contribution versus about US$15m of temporary price, cost and investment headwinds. Record core sales and EBITDA and a target of approximately 90% free cash flow conversion support the idea that the model is getting more cash generative. The catch is that adjusted EBITDA margin slipped 90 bps to 19.5%, so the promised margin step up from mix shift and EBXai efficiency is not yet visible.
Bear case on margins and risk gets support
Skeptics focus on ESAB’s margin pressure, reliance on acquisitions and rising legal and financial risk. Q2 data gives them some clear talking points. Reported net income from continuing operations fell 51.2% year on year to US$33.4m and basic EPS declined 52.2% to US$0.54, while trailing net margin sits at 6.5% versus 10.2% a year earlier. The adjusted EBITDA margin dip to 19.5% and management’s own reference to price or cost neutrality and higher logistics and commodity costs show profitability under strain even as revenue grows. The Eddyfi deal lifts guided EBITDA but management still flags modest EPS dilution near term and relatively high SG&A that needs scaling, which fits concerns about acquisition driven growth. The South Carolina asbestos ruling and talk of an “existential” liability overhang meanwhile keeps legal risk squarely in view alongside the recent 2.8% share price decline after earnings.
After a 52% decline in quarterly EPS and profit margins now tracking at 6.5%, you may want to know whether this is a temporary earnings wobble or a sign of deeper structural strain inside ESAB. Review the independent risk analysis for ESAB which shows 2 important warning signsTake Charge Of Your Next Move
If ESAB's 52% quarterly EPS decline and 6.5% net margin have your attention, register for free with Simply Wall St and add ESAB to a Watchlist so you can track its share price against fair value and wait for an entry point that fits your plan. Once you decide to own the stock, use the Portfolio Command Center to cut through noise and get focused updates on earnings, risks and valuation changes for ESAB and your other holdings. Round this out by tapping into crowd insights through the Community so you can see how other investors are thinking about the same pressure points. By spotting potential catalysts and red flags early, you give yourself a better chance to stay ahead of the market instead of reacting after the fact.
Seeking Alternatives Beyond ESAB Stock?
Fresh ideas move fast. Some stocks build quiet breakout momentum while others risk dropping off radars. Scan curated opportunities before the crowd catches on and act now.
- Spot income workhorses with payout strength that might support portfolios while prices are still under the radar for now by checking the 8 dividend fortresses.
- Chase potential early momentum in companies tied to data centers and chips before sentiment is fully priced in by reviewing the 55 AI infrastructure stocks.
- Track potential future growth stories in frontier computing while they are still flying under most screens by running the 26 quantum computing stocks.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
